ACR Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 18.00%

Insider Buying (Last 12 Months): A$30,060.53

Insider Selling (Last 12 Months): A$0.00

Acrux Insider Trading History Chart

Acrux Share Price & Price History

A^$0.00

+0.30 (1.20%)

As of 05/13/2020 01:00 AM ET

Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THIS

From Paradigm Press | Ad

You might have seen that Bitcoin was one of the best performing assets of 2023. It gained 164%. But a crypto millionaire who has been tracking the space for more than a decade has ABANDONED Bitcoin. He found something better.

Click here to find out that this 8,788% cryptocurrency is.

Acrux Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction
3/5/2024	Ross Dobinson	Insider	Exercise	418,851	A$0.06	A$23,036.81
12/20/2023	Timothy Oldham	Insider	Buy	414,561	A$0.05	A$18,655.25
12/5/2023	Geoffrey Brooke	Insider	Issued	1,062,946	A$0.05	A$52,084.35
11/24/2023	Ross Dobinson	Insider	Exercise	237,610	A$0.04	A$10,217.23
8/30/2023	Ross Dobinson	Insider	Buy	237,610	A$0.05	A$11,405.28
6/16/2023	Geoffrey Brooke	Insider	Exercise	138,187	A$0.05	A$6,356.60
5/24/2023	Ross Dobinson	Insider	Exercise	237,610	A$0.05	A$10,930.06
3/31/2023	Geoffrey Brooke	Insider	Buy	138,187	A$0.06	A$8,291.22
3/9/2023	Donald Brumley	Insider	Buy	1,455,000	A$0.06	A$91,665.00
3/1/2023	Donald Brumley	Insider	Exercise	138,187	A$0.06	A$8,429.41
12/1/2022	Ross Dobinson	Insider	Exercise	81,950	A$0.07	A$5,900.40
11/25/2022	Timothy Oldham	Insider	Issued	552,748	A$0.07	A$37,586.86
10/28/2022	Geoffrey Brooke	Insider	Exercise	614,721	A$0.08	A$50,407.12
8/30/2022	Donald Brumley	Insider	Exercise	59,555	A$0.06	A$3,573.30
6/22/2022	Timothy Oldham	Insider	Exercise	646,110	A$0.07	A$42,643.26
5/23/2022	Donald Brumley	Insider	Buy	57,614	A$0.07	A$4,090.59
3/15/2022	Donald Brumley	Insider	Exercise	171,546	A$0.09	A$15,267.59
11/29/2021	Donald Brumley	Insider	Buy	750,000	A$0.12	A$89,250.00
11/26/2021	Donald Brumley	Insider	Issued	347,624	A$0.12	A$42,062.50
9/15/2021	Ross Dobinson	Insider	Exercise	81,944	A$0.14	A$11,472.16
6/15/2021	Ross Dobinson	Insider	Exercise	81,944	A$0.12	A$9,423.56

Biden’s $374B Giveaway Into This Sector

From DTI | Ad

Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here

Click here for the full story

SEC Filings (Institutional Ownership Changes) for Acrux (ASX:ACR)

12.22% of Acrux stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Acrux Limited, together with its subsidiaries, develops and commercializes generic and topical pharmaceuticals in Australia, Europe, the United States, and internationally. The company offers testosterone solutions, such as oral tablets, buccal tablets, subcutaneous pellets, transdermal patches, injections, and topical gels for treatment of males. It also provides estradiol transdermal sprays for women under the Evamist and Lenzetto brand names for the treatment of flushes associated with menopause; and lidocaine and prilocaine cream, a generic version of EMLA cream, which is indicated as a topical anaesthetic for use on normal intact skin for local analgesia, and genital mucous membranes for superficial minor surgery and as a pre-treatment for infiltration anaesthesia. The company was incorporated in 1998 and is based in West Melbourne, Australia.

Today's Range

Now: N/A

50 Day Range

MA: N/A

52 Week Range

Now: N/A

Volume

4,000 shs

Average Volume

N/A

Market Capitalization

N/A

P/E Ratio

N/A

Dividend Yield

11.66%

Beta

1.19

Who are the company insiders with the largest holdings of Acrux?: Acrux's top insider shareholders include:
Donald Brumley (Insider)
Geoffrey Brooke (Insider)
Ross Dobinson (Insider)
Timothy Oldham (Insider)
Learn More about top insider investors at Acrux.